Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoingPhase 1: 83% ORR at RP2D and 100% ORR in the target Phase ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating payloads, today announced that the Company will ...
THE WOODLANDS, Texas and HUMMELSTOWN, Pa., March 17, 2026 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a ...
AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers: Cambridge, UK Tu ...
Harvard University turned over the photos to the International African American Museum in Charleston after a seven-year legal ...
-- Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio -- Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release -- Commit is poised to ...
Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when she was dying of cervical cancer. By Michael Levenson The pharmaceutical ...
Hosted on MSN
Tips on how to improve without changing swing
In this video Neil Tappin, Digital Editor of Golf Monthly explains: How can you play better golf without changing your swing with guest Nick Dougherty. In association with Taylor Made. Latest update ...
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...
A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell therapies without suppressing the immune system, a serious side effect. The ...
Matthew Hoffmann receives funding from Social Science and Humanities Research Council and the Lawson Climate Institute. University of Toronto provides funding as a founding partner of The Conversation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results